Anti-LHX3 antibody [EPR3344(2)] (ab124697)


  • Product name
    Anti-LHX3 antibody [EPR3344(2)]
    See all LHX3 primary antibodies
  • Description
    Rabbit monoclonal [EPR3344(2)] to LHX3
  • Tested applications
    Suitable for: WB, IP, Flow Cytmore details
    Unsuitable for: ICC or IHC-P
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide, corresponding to residues from Human LHX3.

  • Positive control
    • 293T and Jurkat cell lysates, Human brain and fetal lung tissue lysates; permeabilized Jurkat cells.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.


Associated products


Our Abpromise guarantee covers the use of ab124697 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Detects a band of approximately 43 kDa (predicted molecular weight: 43 kDa).
IP 1/10 - 1/100.
Flow Cyt 1/10 - 1/100. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
  • Application notes
    Is unsuitable for ICC or IHC-P.
  • Target

    • Function
      Acts as a transcriptional activator. Binds to and activates the promoter of the alpha-glycoprotein gene, and synergistically enhances transcription from the prolactin promoter in cooperation with Pit-1.
    • Involvement in disease
      Defects in LHX3 are the cause of pituitary hormone deficiency combined type 3 (CPHD3) [MIM:221750]; also known as combined pituitary hormone deficiency with rigid cervical spine or sensorineural deafness with pituitary dwarfism. CPHD is characterized by a complete deficit in all but one (adrenocorticotropin) anterior pituitary hormone and a rigid cervical spine leading to limited head rotation.
    • Sequence similarities
      Contains 1 homeobox DNA-binding domain.
      Contains 2 LIM zinc-binding domains.
    • Domain
      The LIM domain specifically interacts with the Pit-1 POU domain and is required for synergistic interactions with Pit-1, but not for basal transcriptional activation events.
    • Cellular localization
    • Information by UniProt
    • Database links
    • Alternative names
      • CPHD 3 antibody
      • CPHD3 antibody
      • DKFZp762A2013 antibody
      • LHX 3 antibody
      • LHX3 antibody
      • LHX3_HUMAN antibody
      • LIM 3 antibody
      • LIM homeobox 3 antibody
      • LIM homeobox gene 3 antibody
      • LIM homeobox protein 3 antibody
      • LIM/homeobox protein Lhx3 antibody
      • LIM/homeodomain protein LHX3 antibody
      • Lim3 antibody
      • M2 LHX3 antibody
      • mLim-3 antibody
      • mLIM3 antibody
      • P LIM antibody
      see all

    Anti-LHX3 antibody [EPR3344(2)] images

    • All lanes : Anti-LHX3 antibody [EPR3344(2)] (ab124697) at 1/1000 dilution

      Lane 1 : 293T cell lysate
      Lane 2 : Human brain tissue lysate
      Lane 3 : Jurkat cell lysate
      Lane 4 : Human fetal lung lysate

      Lysates/proteins at 10 µg per lane.

      Goat anti-Rabbit HRP at 1/2000 dilution

      Predicted band size : 43 kDa
    • ab124697 at 1/10 dilution, staining LHX3 in permeabilized Jurkat cells by flow cytometry (red), compared with a negative control Rabbit IgG antibody (green).
    • Equilibrium disassociation constant (KD)
      Learn more about KD

      Click here to learn more about KD

    References for Anti-LHX3 antibody [EPR3344(2)] (ab124697)

    ab124697 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab124697.
    Please use the links above to contact us or submit feedback about this product.


    Sign up